240 filings
Page 4 of 12
8-K
3nf27pfhnzyam aif7kx
20 Dec 21
Departure of Directors or Certain Officers
8:00am
8-K
dgyb46 0m0ecb
22 Nov 21
Regulation FD Disclosure
8:42am
8-K
29bmi8dxks jau7fz
3 Nov 21
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
y57o7ram
14 Oct 21
CRISPR Therapeutics Announces Transition of Chief Financial Officer
7:15am
8-K
smf0zbibgz2vmdeo5
12 Oct 21
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed
4:46pm
S-3ASR
ji310xc0rk2ktf mxwh7
29 Jul 21
Automatic shelf registration
5:17pm
8-K
uubrk15h1r 58
29 Jul 21
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
4:34pm
8-K
pzq6 6h0joa
14 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:52pm
8-K
0nj6088 www4
11 Jun 21
Regulation FD Disclosure
7:10am
8-K
wk8cx0yujuw2u d5aa
2 Jun 21
Other Events
9:16am
DEFA14A
1y9ed 9lp
28 Apr 21
Additional proxy soliciting materials
4:22pm
8-K
m7aicc zxn1
27 Apr 21
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
4:05pm
8-K
cxd hcutbi292lcf
20 Apr 21
Entry into a Material Definitive Agreement
7:22am
8-K
pof5psfk
16 Feb 21
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm